Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Aug 31;12:758130. doi: 10.3389/fphar.2021.758130

Erratum: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

Frontiers Production Office1,*
PMCID: PMC8438299  PMID: 34531757

Due to a production error, several author names were incorrectly written. The names of Omar S. Al-Odat, Robert J. Chitren, Weam O. Elbezanti, Sandeep K. Srivastava, Subash C. Jonnalagadda, and Bharat B. Aggarwal had their initials mistakenly omitted.

The publisher apologizes for this mistake.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES